6th Australian Translational Breast Cancer Research Symposium 2022

The Australian Translational Breast Cancer Research Symposium is a one-of-a-kind event in the Australian research meeting. Its objective is to bring together the large breast cancer research community, spanning basic researchers and clinicians, for two days of updates in cutting edge translational breast research.

The plenary speakers for the 2022 meeting are Charles Perou (University of North Carolina), Prue Francis (Peter Mac) and Sherene Loi (Peter Mac). We have also assembled a national faculty of key leaders in breast cancer research.


The key themes for the 2022 meeting are:

  • Insights from Large Cohort studies
  • Novel Therapeutic Strategies
  • ER+ breast cancer
  • Immune system and Microenvironment


Registrations are limited to 350 places; and are kindly supported by our generous sponsors.

We encourage researchers and clinicians of all stages of their careers to join us.


Symposium details


  • Thursday 6th - Friday 7th October 2022



  • Free.

Register now

Organising Committee

  • Elgene Lim, Alex Swarbrick 



Alex Swarbrick (Garvan)

Andrew Redfern (UWA)

Arcadi Cipponi (Garvan)

Bhupinder Pal (ONJRI)

Bruce Mann (Royal Melb Hospital)

Christine Chaffer (Garvan)

Charles Perou (University of North Carolina)

David Gallego (UTS)

Fiona Simpson (UQ)

Jane Visvader (WEHI)

Joakim Lundeberg (KTH Royal Institute of Technology, Sweden)

Pilar Blancafort (UWA)

Prue Francis (Peter Mac)

Sean Grimmond (VCCC)

Sherene Loi (Peter Mac)

Sue Clark (Garvan)

Tatyana Chtanova (Garvan)

Theresa Hickey (Uni Adelaide)

Thomas Cox (Garvan)


Please note program may be subject to change

Thursday 6th Oct 2022

9.00am: Registration opens

9.30am: Welcome by Elgene Lim (Garvan) and Alex Swarbrick (Garvan)

9.40am: Patient Reflection: Ms Renee Chahine


Session 1: Insights from Large Cohort studies

Chair: Sunil Lakhani (Uni Queensland) and Sue Clark (Garvan)

9.50am: Plenary I: Charles Perou (University of North Carolina) – Insights into mechanisms of therapeutic resistance

10.20am: Andrew Redfern (UWA) – Breast Cancer in the Indigenous Australian 

10.35am: Bruce Mann (Royal Melb Hospital) - Controversies in the management of stage 0 and 1 breast cancer

10.50am: Jane Visvader (WEHI): Exploring normal and malignant breast tissue at the single cell level

11.05am: Alex Swarbrick (Garvan) – Exploring the ecosystem of breast cancer metastases at single cell resolution

11.20am: Panel Discussion


12-1pm: Lunch and networking


Session 2: Novel Therapeutic Strategies

Chair: David Croucher (Garvan) and Andrew Redfern (Uni WA)

1.00pm: Plenary II: Prue Francis (Peter Mac) – Clinical Controversies in the management of ER+ Early Breast Cancer

1.30pm: Pilar Blancafort (UWA) - Metabolic reprograming in ER+ BC

1.45pm: Fiona Simpson (UQ) – Repurposing of stemetil to improve antiHER2 therapy response.

2.00pm: Sue Clark (Garvan) – Epigenetic landscape of treatment resistant breast cancer

2.15pm: Panel Discussion


2.45-3.15pm: Coffee Networking


Session 3: Novel Therapeutic Strategies II

Chair: Wayne Tilley (Uni Adelaide) and Clare Stirzaker (Garvan)

3.15pm: Sean Grimmond (VCCC) - The COLUMN initiative (rapid challenging patient sequencing platform)

3.30pm: Arcadi Cipponi (Garvan) – Targeting Error prone DNA repair pathways

3.45pm: Theresa Hickey (Uni Adelaide) – Targeting CDK9 in TNBC.

4.00pm: Christine Chaffer (Garvan) – Targeting EMT In breast cancer

4.15pm: Liz Caldon (Garvan) - Possibilities for PARP inhibition in breast cancer

4.30pm: Panel Discussion


5:00-6:00pm: Posters, Wine, Canapés and Networking

Chair: David Hermann (Garvan) and Leila Eshraghi (Garvan)


6.30pm - late: Faculty Dinner

The Butler, 123 Victoria St, Potts Point.

Read more